Allicin, an Emerging Treatment for Pulmonary Arterial Hypertension: An Experimental Study

Allicin, an Emerging Treatment for Pulmonary Arterial Hypertension: An Experimental Study

We assessed whether allicin, through its antihypertensive and antioxidant effects, relieves vascular remodeling, endothelial function, and oxidative stress (OS), thereby improving experimental pulmonary arterial hypertension (PAH). Allicin (16 mg/kg) was administered to rats with PAH (monocrotaline...

Full description

Bibliographic Details
Main Authors: José L. Sánchez-Gloria, Constanza E. Martínez-Olivares, Leonardo Del Valle-Mondragón, Fernando Cortés-Camacho, Oscar R. Zambrano-Vásquez, Rogelio Hernández-Pando, Fausto Sánchez-Muñoz, Laura G. Sánchez-Lozada, Horacio Osorio-Alonso
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
allicin
pulmonary arterial hypertension
endothelial function
renin–angiotensin system
oxidative stress
hypoxia
Online Access:https://www.mdpi.com/1422-0067/24/16/12959

Internet

https://www.mdpi.com/1422-0067/24/16/12959

Similar Items